Study of the Interest of Proprioceptive Therapy as a Complement to Speech Therapy in Children With Reading Difficulties (2000DYS9)

August 5, 2016 updated by: Centre Hospitalier Universitaire Dijon

Before proposing this observational study protocol, a randomized study was attempted. This consisted in proposing to families of children with difficulties in learning to read, via the speech therapists who were treating them, to take part in a randomized trial that compared speech therapy alone with a combination of speech therapy and proprioceptive therapy. If parents agreed in principle with the study, the child underwent a complementary speech therapy examination and was referred to the nearest investigating doctor for inclusion. However, this study had to be abandoned because of insufficient recruitment (2 patients included in 1 year). Despite the motivation and training of participating speech therapists, proposing a study based on randomization to families often in distress proved to be extremely difficult, as their conviction of the interest of proprioceptive therapy was greater than the available scientific evidence suggested. Direct recruitment by investigating ophthalmologists was not possible because they were consulted directly by the families so as to obtain proprioceptive therapy. The principle of randomization would thus not have been accepted.

In light of the above, we decided to turn towards a non-randomized study comparing outcomes in two groups of children:

  • children who consulted an ophthalmologist who proposed proprioceptive therapy in Côte d'Or
  • children managed by one of the four speech therapists who do not propose proprioceptive therapy and who accepted the principle of the study.

Study Overview

Status

Unknown

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21079
        • Recruiting
        • CHU Dijon Bourgogne
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

For both groups:

  • children at school and between the end of year 3 and the end of year 7
  • with speech therapy for reading difficulties
  • with a delay of 18 months or more compared with children in the same group at inclusion
  • who had never had proprioceptive therapy
  • in cases of two or more siblings with reading difficulties between year 3 and year 8, only one child will be included.
  • With one speech therapy session per week
  • Who have accepted to take part in the study in agreement with their parents
  • With national health insurance cover For the " speech therapy only" cohort: children followed by speech therapists who do not usually refer their patients to ophthalmologists that use proprioceptive therapy in cases of delayed reading acquisition and have not previously consulted an ophthalmologist proposing this type of therapy.

For the " speech therapy associated with proprioceptive therapy " cohort: children with reading difficulties followed by a speech therapist and consulting for the first time an ophthalmologist, study investigator, who uses proprioceptive therapy in the treatment of reading difficulties.

Exclusion Criteria:

  • Children who lack motivation and/or and those unlikely to be followed in optimal conditions
  • Neonatal distress: APGAR <7
  • Gestational age < 37 weeks of Amenorrhea (WA)
  • Genetic disease
  • Known abnormal or delay in psychomotor development
  • Psychiatric disorder
  • Sensory deficit or disorder known to limit the possibilities of proprioceptive therapy
  • Children undergoing treatment, notably psychotropic agents, Ritaline®, antiepileptic agents or rehabilitation, which may interfere with reading difficulties or the therapy proposed in the study
  • Children in special needs schools (SEGPA)
  • Children who cannot attend all of the consultations planned in the protocol for practical reasons.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: proprioceptive therapy
Placebo Comparator: speech therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of children who had stabilized their delay in reading acquisition at the Timé-3 test (identification of written words)
Time Frame: At month12
At month12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Anticipated)

July 1, 2017

Study Registration Dates

First Submitted

August 5, 2016

First Submitted That Met QC Criteria

August 5, 2016

First Posted (Estimate)

August 10, 2016

Study Record Updates

Last Update Posted (Estimate)

August 10, 2016

Last Update Submitted That Met QC Criteria

August 5, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reading Difficulties

Clinical Trials on speech therapy

Subscribe